Market Overview

Morning Market Losers

Share:
Related ARIA
ARIAD and Medison Pharma Announce Approval of Iclusig (Ponatinib) in Israel
JMP Feeling Mostly Good On 4 Drug, Healthcare Stocks
Related LRN
Lost Money On K12 Shares In Late 2013? Wait Until You See What Management Kept From You...It's Not Pretty
K12 Inc. is Expanding in Midst of Headwinds and Changing Dynamics

Ariad Pharmaceuticals (NASDAQ: ARIA) plummeted 72.81% to $4.66 after the company reported that it is pausing patient enrollment in studies of Iclusig.

K12 (NYSE: LRN) dropped 36.45% to $18.17 on lower outlook. BMO Capital downgraded the stock from Outperform to Market Perform.

Pretium Resources (NYSE: PVG) dropped 22.59% to $5.24. shares have dropped 49.78% over the past 52 weeks, while the S&P 500 index has gained 15.56% in the same period.

CytRx (NASDAQ: CYTR) dropped 18.07% to $2.2450 after the company priced its underwritten public offering of 10.0 million shares of common stock at a price of $2.25 per share.

Posted-In: market losersNews Movers & Shakers Intraday Update Markets

 

Related Articles (ARIA + CYTR)

Around the Web, We're Loving...